No Data
No Data
Renovaro | 10-Q: Quarterly report
RenovaroCube, Wholly Owned Subsidiary Of Renovaro, Unveils Flamingo, A Multi-Cancer Detection Model Contributing To Its Mission To Transform Early Cancer Diagnostics
RenovaroCube, wholly owned subsidiary of Renovaro, Inc. (NASDAQ:RENB), a company at the forefront of AI-driven healthcare innovation, proudly unveils Flamingo, a potentially groundbreaking multi-cance
Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a Novel AI Model Based on Fragmentomics
LOS ANGELES and AMSTERDAM, April 30, 2024 (GLOBE NEWSWIRE) -- RenovaroCube, wholly owned subsidiary of Renovaro, Inc. (NASDAQ:RENB), a company at the forefront of AI-driven healthcare innovation, proudly unveils
Applied Dna Sciences, OptimizeRx, SCWorx Among Healthcare Movers
Renovaro Amends Binding Letter of Intent To Acquire 100% Ownership of Cyclomics >RENB
Renovaro Amends Binding Letter of Intent To Acquire 100% Ownership of Cyclomics >RENB
Express News | Renovarocube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
No Data